{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:24:22Z","timestamp":1772119462589,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00520-025-09932-6","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:48:59Z","timestamp":1760111339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Methadone for intractable cancer pain associated with pelvic floor lesions: a retrospective analysis of 36 cases"],"prefix":"10.1007","volume":"33","author":[{"given":"Tetsumi","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiichi","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Fukutomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Kamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Hagiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rei","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"9932_CR1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jmig.2006.06.021","volume":"13","author":"G Lamvu","year":"2006","unstructured":"Lamvu G, Steege JF (2006) The anatomy and neurophysiology of pelvic pain. J Minim Invasive Gynecol 13:516\u2013522. https:\/\/doi.org\/10.1016\/j.jmig.2006.06.021","journal-title":"J Minim Invasive Gynecol"},{"key":"9932_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1365-2982.2006.00803.x","volume":"18","author":"AE Bharucha","year":"2006","unstructured":"Bharucha AE (2006) Pelvic floor: anatomy and function. Neurogastroenterol Motil 18:507\u2013519. https:\/\/doi.org\/10.1111\/j.1365-2982.2006.00803.x","journal-title":"Neurogastroenterol Motil"},{"key":"9932_CR3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1515\/tnsci-2020-0184","volume":"8","author":"I Alkatout","year":"2021","unstructured":"Alkatout I, Wedel T, Page J, Possover M, Dhanawat J (2021) Review: pelvic nerves\u2013from anatomy and physiology to clinical applications. Transl Neurosci 8:362\u2013378. https:\/\/doi.org\/10.1515\/tnsci-2020-0184","journal-title":"Transl Neurosci"},{"key":"9932_CR4","doi-asserted-by":"publisher","unstructured":"Origoni M, Maggiore ULR, Salcatore S, Candiani M (2014) Neurobiological mechanism of pelvic pain. BioMed Res International\u00a01.\u00a0https:\/\/doi.org\/10.1155\/2014\/903848","DOI":"10.1155\/2014\/903848"},{"key":"9932_CR5","volume-title":"Anatomy, abdomen and pelvis, pelvis StatPearls [Internet]","author":"SR Chaudhry","year":"2023","unstructured":"Chaudhry SR, Naihian A, Chaudhry K (2023) Anatomy, abdomen and pelvis, pelvis StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL)"},{"key":"9932_CR6","unstructured":"Bordoni B, Sugumar K, Leslie SW (2023) Anatomy, abdomen and pelvis, pelvic floor. StatPearls, StatPearls Publishing, Treasure Island (FL)"},{"key":"9932_CR7","unstructured":"Bordoni B, Launico MV (2025) Anatomy, abdomen and pelvis, perineal body. StatPearls, StatPearls Publishing, Treasure Island (FL)"},{"key":"9932_CR8","doi-asserted-by":"publisher","unstructured":"Navarro-Zarza JE, Vallase\u00f1or-Ovies, Vargas A, Canoso JJ, Chiapas-Gasca K, Hen\u00e1ndez-D\u00edaz C, Saavedra M\u00c1, Kalish RA (2012) Clinical anatomy of the pelvis and hip. Reumatol Clin\u00a08; Supple 2: 33\u201338.\u00a0https:\/\/doi.org\/10.1016\/j.reuma.2012.10.006","DOI":"10.1016\/j.reuma.2012.10.006"},{"key":"9932_CR9","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.neuroscience.2007.07.053","volume":"149","author":"AP Malykhina","year":"2007","unstructured":"Malykhina AP (2007) Neural mechanisms of pelvic organ cross-sensitization. Neuroscience 149:660\u2013672. https:\/\/doi.org\/10.1016\/j.neuroscience.2007.07.053","journal-title":"Neuroscience"},{"key":"9932_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.pmr.2017.03.003","volume":"28","author":"AM Eickmeyer","year":"2017","unstructured":"Eickmeyer AM (2017) Anatomy and physiology of the pelvic floor. Phys Med Rehabil Clin N Am 28:455\u2013460. https:\/\/doi.org\/10.1016\/j.pmr.2017.03.003","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"9932_CR11","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1200\/JJCO.2010.28.6559","volume":"28","author":"M Kerba","year":"2010","unstructured":"Kerba M, Wu JSY, Duan Q, Hagen NA, Bennett MI (2010) Neuropathic pain features on patients with bone metastases referred for palliative radiotherapy. J Clin Oncol 28:4892\u20134897. https:\/\/doi.org\/10.1200\/JJCO.2010.28.6559","journal-title":"J Clin Oncol"},{"key":"9932_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.pain.2005.02.022","volume":"115","author":"MA Sevcik","year":"2005","unstructured":"Sevcik MA, Ghilardi JR, Peters CM, Lindsay TH, Halvorson KG, Jonas BM, Kubota K, Kuskowski MA, Boustany L, Shelton DL, Mantyh PW (2005) Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization. Pain 115:128\u2013141. https:\/\/doi.org\/10.1016\/j.pain.2005.02.022","journal-title":"Pain"},{"key":"9932_CR13","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1200\/JCO.2013.51.7219","volume":"32","author":"S Falk","year":"2014","unstructured":"Falk S, Dickenson AH (2014) Pain and nociception: mechanism of cancer-induced bone pain. J Clin Oncol 32:1647\u20131654. https:\/\/doi.org\/10.1200\/JCO.2013.51.7219","journal-title":"J Clin Oncol"},{"key":"9932_CR14","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1016\/j.pain.2013.07.044","volume":"154","author":"P Mantyh","year":"2013","unstructured":"Mantyh P (2013) Bone cancer pain: causes, consequences, and therapeutic opportunities. Pain 154:S54\u2013S62. https:\/\/doi.org\/10.1016\/j.pain.2013.07.044","journal-title":"Pain"},{"key":"9932_CR15","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.ejca.2008.03.001","volume":"44","author":"L Calvin","year":"2008","unstructured":"Calvin L, Fallon M (2008) Challenges in cancer pain management-bone pain. Eur J Cancer 44:1083\u20131090. https:\/\/doi.org\/10.1016\/j.ejca.2008.03.001","journal-title":"Eur J Cancer"},{"key":"9932_CR16","doi-asserted-by":"publisher","first-page":"E373","DOI":"10.36076\/ppj.2011\/14\/E373","volume":"14","author":"HS Smith","year":"2011","unstructured":"Smith HS (2011) Painful osseous metastases. Pain Phys 14:E373\u2013E403","journal-title":"Pain Phys"},{"key":"9932_CR17","doi-asserted-by":"publisher","unstructured":"Asiri MD, Banjar R, Al-Qahtani, Goodarzynejad H, Hassouna M (2019) Central nervous system changes in pelvic inflammation\/pain patients. Curr Bladder Dysfunction Rep\u00a014: 223\u2013230. https:\/\/doi.org\/10.1007\/s11884-019-00530-x","DOI":"10.1007\/s11884-019-00530-x"},{"key":"9932_CR18","first-page":"E531","volume":"25","author":"C Patel","year":"2022","unstructured":"Patel C, Patel A, Diwan S (2022) The role of neuromodulation in chronic pelvic pain: a review article. Pain Physician 25:E531\u2013E542","journal-title":"Pain Physician"},{"key":"9932_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2021.642349","volume":"15","author":"W Yu","year":"2021","unstructured":"Yu W, Wu X, Chen Y, Liang Z, Jiang J, Misrani A, Su Y, Peng Y, Chen J, Tang B, Sun M, Long C, Shen J, Yang L (2021) Pelvic pain alters functional connectivity between anterior cingulate cortex and hippocampus in both humans and a rat model. Front Syst Neurosci 15:642349. https:\/\/doi.org\/10.3389\/fnsys.2021.642349","journal-title":"Front Syst Neurosci"},{"key":"9932_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0268355519855598","volume":"35","author":"SG Gavrilov","year":"2020","unstructured":"Gavrilov SG, Vassilieva GY, Grishenkova AS (2020) The role of vasoactive neuropeptides in the genesis of venous pelvic pain: a review. Phlebology 35:4\u20139. https:\/\/doi.org\/10.1177\/0268355519855598","journal-title":"Phlebology"},{"key":"9932_CR21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/1096-9098(200012)75:4<280::aid-jso13>3.0.co;2-q","volume":"75","author":"BM Rigor","year":"2000","unstructured":"Rigor BM (2000) Pelvic cancer pain. J Surg Oncol 75:280\u2013300. https:\/\/doi.org\/10.1002\/1096-9098(200012)75:4<280::aid-jso13>3.0.co;2-q","journal-title":"J Surg Oncol"},{"key":"9932_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0304-3959(85)90081-8","volume":"21","author":"JK Wang","year":"1985","unstructured":"Wang JK (1985) Intrathecal morphine for intractable pain secondary to cancer of pelvic organs. Pain 21:99\u2013102. https:\/\/doi.org\/10.1016\/0304-3959(85)90081-8","journal-title":"Pain"},{"key":"9932_CR23","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.2147\/JPR.S308743","volume":"27","author":"EM Abdelghafar","year":"2021","unstructured":"Abdelghafar EM, Othman AH, Soliman MS, Kilany A, Shaaban MH, Shaker EH (2021) The role of double modality ultrasonographic and fluoroscopic guided superior hypogastric plexus neurolysin in treating intractable pelvic cancer pain: a comparative study. J Pain Res 27:1465\u20131473. https:\/\/doi.org\/10.2147\/JPR.S308743","journal-title":"J Pain Res"},{"key":"9932_CR24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3171\/jns.1981.55.4.0581","volume":"55","author":"CE Poletti","year":"1981","unstructured":"Poletti CE, Cohen AM, Todd DP, Ojemann RG, Sweet WH, Zervas NT (1981) Cancer pain relieved by long-term epidural morphine with permanent indwelling systems for self-administration. J Neurosurg 55:581\u2013584. https:\/\/doi.org\/10.3171\/jns.1981.55.4.0581","journal-title":"J Neurosurg"},{"key":"9932_CR25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/1097-0142(19800201)45:3<432::AID-CNCR2820450305>3.0.CO;2-C","volume":"45","author":"JC Lathrop","year":"1980","unstructured":"Lathrop JC, Frates RE (1980) Arterial infusion of nitrogen mustard in the treatment of intractable pelvic pain of malignant origin. Cancer 45:432\u2013438. 10.1002\/1097-0142(19800201)45:3%3C432::aid-cncr2820450305%3E3.0.co;2-c.","journal-title":"Cancer"},{"key":"9932_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/104990910302000114","volume":"20","author":"NE Slatkin","year":"2003","unstructured":"Slatkin NE, Rhiner M (2003) Phenol saddle blocks for intractable pain at the end of life: report of four cases and literature review. Am J Hosp Palliat Care 20:62\u201366. https:\/\/doi.org\/10.1177\/104990910302000114.","journal-title":"Am J Hosp Palliat Care"},{"key":"9932_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0304-3959(97)00188-8","volume":"73","author":"DR Fitzgibbon","year":"1997","unstructured":"Fitzgibbon DR, Ready B (1997) Intravenous high-dose methadone administered by patient controlled analgesia and continuous infusion for the treatment of cancer pain refractory to high-dose morphine. Pain 73:259\u2013261. https:\/\/doi.org\/10.1016\/S0304-3959(97)00188-8.","journal-title":"Pain"},{"key":"9932_CR28","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1097\/01.ju.0000091656.94825.90","volume":"170","author":"AM Kamat","year":"2003","unstructured":"Kamat AM, Huang SF, Bermejo CE, Rosser CJ, Pettaway CA, Pisters PWT, Guitreau DP, Pisters LL (2003) Todal pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer. J Urol 170:1868\u20131871. https:\/\/doi.org\/10.1097\/01.ju.0000091656.94825.90","journal-title":"J Urol"},{"key":"9932_CR29","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1002\/1097-0142(19930915)72:6<1853::aid-cncr2820720611>3.0.co;2-v","volume":"15","author":"RS Yeung","year":"1993","unstructured":"Yeung RS, Moffat FL, Falk RE (1993) Pelvic exenteration for recurrent and extensive primary colorectal adenocarcinoma. Cancer 15:1853\u20131858. https:\/\/doi.org\/10.1002\/1097-0142(19930915)72:6%3c1853::aid-cncr2820720611%3e3.0.co;2-v","journal-title":"Cancer"},{"key":"9932_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv108","volume":"29","author":"L Posa","year":"2016","unstructured":"Posa L, Accarie A, Noble F, Marie N (2016) Methadone reverses analgesic tolerance induced by morphine pretreatment. Int J Neuropsychopharmacol 29:pyv108. https:\/\/doi.org\/10.1093\/ijnp\/pyv108","journal-title":"Int J Neuropsychopharmacol"},{"key":"9932_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5055\/jom.2007.0048","volume":"3","author":"DJ Axelrod","year":"2007","unstructured":"Axelrod DJ, Reville B (2007) Using methadone to treat opioid-induced hyperalgesia and refractory pain. J Opioid Manag 3:113\u2013114. https:\/\/doi.org\/10.5055\/jom.2007.0048","journal-title":"J Opioid Manag"},{"key":"9932_CR32","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3109\/15360288.2015.1082006","volume":"29","author":"V Carullo","year":"2015","unstructured":"Carullo V, Fitz-James I, Delphin E (2015) Opioid-induced hyperalgesia: a diagnostic dilemma. J Pain Palliat Care Pharmacother 29:378\u2013384. https:\/\/doi.org\/10.3109\/15360288.2015.1082006","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"9932_CR33","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3109\/15360288.2011.589490","volume":"25","author":"C Ramasubbu","year":"2011","unstructured":"Ramasubbu C, Gupta A (2011) Pharmacological treatment of opioid-induced hyperalgesia: a review of the evidence. J Pain Palliat Care Pharmacother 25:219\u2013230. https:\/\/doi.org\/10.3109\/15360288.2011.589490","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"9932_CR34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jpain.2020.04.004","volume":"22","author":"V Hanna","year":"2021","unstructured":"Hanna V, Senderovich H (2021) Methadone in pain management: a systematic review. J Pain 22:233\u2013245. https:\/\/doi.org\/10.1016\/j.jpain.2020.04.004.","journal-title":"J Pain"},{"key":"9932_CR35","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/pgmj.2004.022988","volume":"80","author":"R Brown","year":"2004","unstructured":"Brown R, Kraus C, Fleming M, Reddy S (2004) Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Postgrad Med J 80:654\u2013659. https:\/\/doi.org\/10.1136\/pgmj.2004.022988.","journal-title":"Postgrad Med J"},{"key":"9932_CR36","first-page":"435","volume":"71","author":"CE Inturrisi","year":"2005","unstructured":"Inturrisi CE (2005) Pharmacology of methadone and its isomers. Minerva Anestesiol 71:435\u2013437","journal-title":"Minerva Anestesiol"},{"issue":"Suppl 1","key":"9932_CR37","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.4103\/IJPC.IJPC_180_17","volume":"24","author":"MM Sunilkumar","year":"2018","unstructured":"Sunilkumar MM, Lockman K (2018) Practical pharmacology of methadone: a long-acting opioid. Indian J Palliat Care 24(Suppl 1):S10\u2013S14. https:\/\/doi.org\/10.4103\/IJPC.IJPC_180_17","journal-title":"Indian J Palliat Care"},{"key":"9932_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/J354v19n04_05","volume":"19","author":"RA Lugo","year":"2005","unstructured":"Lugo RA, Satterfield KL, Kern SE (2005) Pharmacokinetics of methadone. J Pain Palliat Care Pharmacother 19:13\u201324","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"9932_CR39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jcrc.2016.03.023","volume":"34","author":"JL Elefritz","year":"2016","unstructured":"Elefritz JL, Murphy CV, Papadimos TJ, Lyaker MR (2016) Methadone analgesia in the critically ill. J Crit Care 34:84\u201388. https:\/\/doi.org\/10.1016\/j.jcrc.2016.03.023","journal-title":"J Crit Care"},{"key":"9932_CR40","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1177\/104990910001700314","volume":"17","author":"WL Wheeler","year":"2000","unstructured":"Wheeler WL, Dickerson ED (2000) Clinical application of methadone. Am J Hosp Palliat Care 17:196\u2013203. https:\/\/doi.org\/10.1177\/104990910001700314","journal-title":"Am J Hosp Palliat Care"},{"key":"9932_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11916-009-0006-0","volume":"13","author":"JA Trafton","year":"2009","unstructured":"Trafton JA, Ramani A (2009) Methadone: a new old drug with promises and pitfalls. Curr Pain Headache Rep 13:24\u201330. https:\/\/doi.org\/10.1007\/s11916-009-0006-0","journal-title":"Curr Pain Headache Rep"},{"key":"9932_CR42","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/j.1742-1241.2008.01990.x","volume":"63","author":"W Leppert","year":"2009","unstructured":"Leppert W (2009) The role of methadone in cancer pain treatment-a review. Int J Clin Pract 63:1095\u20131109. https:\/\/doi.org\/10.1111\/j.1742-1241.2008.01990.x","journal-title":"Int J Clin Pract"},{"key":"9932_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1089\/10966210252785097","volume":"5","author":"E Bruera","year":"2002","unstructured":"Bruera E, Sweeney C (2002) Methadone use in cancer patients with pain: a review. J Palliat Med 5:127\u2013138. https:\/\/doi.org\/10.1089\/10966210252785097","journal-title":"J Palliat Med"},{"key":"9932_CR44","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/s0889-8588(02)00017-5","volume":"16","author":"C Ripamonti","year":"2002","unstructured":"Ripamonti C, Bianchi M (2002) The use of methadone for cancer pain. Hematol Oncol Clin North Am 16:543\u2013555. https:\/\/doi.org\/10.1016\/s0889-8588(02)00017-5","journal-title":"Hematol Oncol Clin North Am"},{"key":"9932_CR45","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/bjaceaccp\/mkv023","volume":"16","author":"J Rajan","year":"2016","unstructured":"Rajan J, Scott-Warren J (2016) The clinical use of methadone in cancer and chronic pain medicine. Br J Anaesth Educ 16:102\u2013106. https:\/\/doi.org\/10.1093\/bjaceaccp\/mkv023","journal-title":"Br J Anaesth Educ"},{"key":"9932_CR46","doi-asserted-by":"publisher","first-page":"495","DOI":"10.4103\/IJPC.IJPC_9_20","volume":"26","author":"P Glue","year":"2020","unstructured":"Glue P, Sarma R, Sirohiya P, Tatre BK, Bhatnagar S (2020) Breaking the barrier: challenges of methadone use \u2013 an introductory observation. Indian J Palliat Care 26:495\u2013499. https:\/\/doi.org\/10.4103\/IJPC.IJPC_9_20","journal-title":"Indian J Palliat Care"},{"key":"9932_CR47","doi-asserted-by":"publisher","first-page":"7613","DOI":"10.3390\/curroncol31120561","volume":"31","author":"F Ragaban","year":"2024","unstructured":"Ragaban F, Purohit O, Fabbro ED (2024) Methadone in cancer-related neuropathic pain: a narrative review. Curr Oncol 31:7613\u20137624. https:\/\/doi.org\/10.3390\/curroncol31120561","journal-title":"Curr Oncol"},{"issue":"e2","key":"9932_CR48","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1136\/bmjspcare-2021-003220","volume":"13","author":"A Fawoubo","year":"2023","unstructured":"Fawoubo A, Perceau-Chambard \u00c9, Ruer M, Filbet M, Tricou C, Economos G (2023) Methadone and neuropathic cancer pain subcomponents: a prospective cohort pilot study. BMJ Support Palliat Care 13(e2):e273\u2013e277. https:\/\/doi.org\/10.1136\/bmjspcare-2021-003220.","journal-title":"BMJ Support Palliat Care"},{"key":"9932_CR49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/08258597211016564","volume":"37","author":"Y Matsuda","year":"2022","unstructured":"Matsuda Y, Okayama S (2022) Oral methadone for patients with neuropathic pain due to neoplastic brachial plexopathy. J Palliat Care 37:77\u201382. https:\/\/doi.org\/10.1177\/08258597211016564.","journal-title":"J Palliat Care"},{"key":"9932_CR50","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1089\/jpm.2015.0303","volume":"19","author":"Y Sugiyama","year":"2016","unstructured":"Sugiyama Y, Sakamoto N, Ohsawa M, Onizuka M, Ishida K, Murata Y, Iio A, Sugano K, Maeno K, Takeyama H, Akechi T, Kimura K (2016) A retrospective study on the effectiveness of switching to oral methadone for relieving severe cancer-related neuropathic pain and limiting adjuvant analgesic use in Japan. J Palliat Med 19:1051\u20131059. https:\/\/doi.org\/10.1089\/jpm.2015.0303","journal-title":"J Palliat Med"},{"key":"9932_CR51","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejca.2016.08.028","volume":"68","author":"X Ruan","year":"2016","unstructured":"Ruan X, Luo JJ, Kaye AD (2016) Methadone is superior to fentanyl in treating neuropathic pain in patients with head-and-neck cancer. Eur J Cancer 68:199\u2013200. https:\/\/doi.org\/10.1016\/j.ejca.2016.08.028.","journal-title":"Eur J Cancer"},{"key":"9932_CR52","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00774-022-01382-y","volume":"41","author":"D Takei","year":"2023","unstructured":"Takei D, Tagami K (2023) Management of cancer pain due to bone metastasis. J Bone Miner Metab 41:327\u2013336. https:\/\/doi.org\/10.1007\/s00774-022-01382-y","journal-title":"J Bone Miner Metab"},{"key":"9932_CR53","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s00520-020-05606-7","volume":"29","author":"M Sulistio","year":"2021","unstructured":"Sulistio M, Wojnar R, Key S, Kwok J, Al-Rubale A, Michael N (2021) The role of methadone in cancer-induced bone pain: a retrospective cohort study. Support Care Cancer 29:1327\u20131335. https:\/\/doi.org\/10.1007\/s00520-020-05606-7","journal-title":"Support Care Cancer"},{"key":"9932_CR54","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1093\/oncolo\/oyae094","volume":"29","author":"M Aapro","year":"2024","unstructured":"Aapro M, Fogli S, Morlion B, Danesi R (2024) Opioid metabolism and drug-drug interaction in cancer. Oncologist 29:931\u2013942. https:\/\/doi.org\/10.1093\/oncolo\/oyae094","journal-title":"Oncologist"},{"key":"9932_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/life12050679","volume":"12","author":"P F\u00fcrst","year":"2022","unstructured":"F\u00fcrst P (2022) The use of low-dose methadone as add-on to ongoing opioid treatment in palliative cancer care-an underrated treatment? Life 12:679. https:\/\/doi.org\/10.3390\/life12050679.","journal-title":"Life"},{"key":"9932_CR56","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/jjco\/hyae156","volume":"55","author":"T Sato","year":"2025","unstructured":"Sato T, Fukutomi A, Kawamura T, Kawakami K, Sato T, Kamo Y, Suzuki T, Hagiya S, Tanaka R (2025) Low-dose add-on methadone for cancer pain management: a retrospective analysis of 102 Japanese patients. Jap J Clin Oncol 55:123\u2013130. https:\/\/doi.org\/10.1093\/jjco\/hyae156","journal-title":"Jap J Clin Oncol"},{"key":"9932_CR57","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s00520-024-08835-2","volume":"32","author":"E Treillet","year":"2024","unstructured":"Treillet E, Perceau-Chambard E, Economos G, Chevalier L, Picard S, Frasca M, Pouget J, Calvel L, Tremellat-Faliere F, Majerus M, Quesnel PA, Chiquet R, Evin A, Seveque M-A, Lebel A, Hardouin I, Burnod A, Renard O, Bessodes P, Giet O, Serresse L (2024) Low-dose methadone added to another opioid for cancer pain: a multicenter prospective study. Support Care Cancer 32:716. https:\/\/doi.org\/10.1007\/s00520-024-08835-2.","journal-title":"Support Care Cancer"},{"key":"9932_CR58","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1089\/jpm.2015.0525","volume":"19","author":"F Courtemanche","year":"2016","unstructured":"Courtemanche F, Dao D, Gagn\u00e9 F, Tremblay L, N\u00e9ron A (2016) Methadone as a coanalgesic for palliative care cancer patients. J Palliat Med 19:972\u2013978. https:\/\/doi.org\/10.1089\/jpm.2015.0525.","journal-title":"J Palliat Med"},{"key":"9932_CR59","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1089\/pmr.2023.0061","volume":"5","author":"T Sato","year":"2024","unstructured":"Sato T, Ono S, Sato T, Tanaka R, Kamo Y, Suzuki T (2024) Safety and efficacy of combined injection of pure-\u03bc-opioid agonist with tramadol as an opioid induction agent for opioid-na\u00efve cancer patients. Palliat Med Rep 5:340\u2013349. https:\/\/doi.org\/10.1089\/pmr.2023.0061.","journal-title":"Palliat Med Rep"},{"key":"9932_CR60","doi-asserted-by":"publisher","first-page":"457","DOI":"10.15386\/cjmed-500","volume":"88","author":"AO Zgaia","year":"2015","unstructured":"Zgaia AO, Irimie A, Sandesc D, Vlad C, Lisencu C, Rogobete A, Achimas-Cadariu P (2015) The role of ketamine in the treatment of chronic cancer pain. Clujul Med 88:457\u2013461. https:\/\/doi.org\/10.15386\/cjmed-500","journal-title":"Clujul Med"},{"key":"9932_CR61","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s40263-019-00618-2","volume":"33","author":"D Kreutzwiser","year":"2019","unstructured":"Kreutzwiser D, Tawfic QA (2019) Expanding role of NMDA receptor antagonists in the management of pain. CNS Drugs 33:347\u2013374. https:\/\/doi.org\/10.1007\/s40263-019-00618-2","journal-title":"CNS Drugs"},{"key":"9932_CR62","doi-asserted-by":"publisher","first-page":"e1652","DOI":"10.1212\/WNL.0000000000007238","volume":"92","author":"T Thompson","year":"2019","unstructured":"Thompson T, Whiter F, Gallop K, Veronese N, Solmi M, Newton P, Stubbs B (2019) NMDA receptor antagonists and pain relief: a meta-analysis of experimental trials. Neurology 92:e1652\u2013e1662. https:\/\/doi.org\/10.1212\/WNL.0000000000007238","journal-title":"Neurology"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09932-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09932-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09932-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T19:03:32Z","timestamp":1763406212000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09932-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["9932"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09932-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6389982\/v1","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board for Clinical Researches of the Shizuoka Cancer Center (#J2023-57\u20132023-1\u20133) and was conducted with the consent of the patients or their families. After an IRB review, it was determined that consent to participate in the research would be approved by opting out, and that it was not necessary to obtain written informed consent from all subjects. In addition, this research was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants proved informed consent for publication of the clinical data shown in the text and figures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"928"}}